FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB

FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB Stock

DE000SB01Q81

Real-time Boerse Frankfurt Warrants 12:33:57 2024-06-03 EDT
0.003 ^EUR	+50.00%

3 months	-95.74%
6 months	-95.92%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart BRISTOL-MYERS SQUIBB COMPANY

Chart FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB

Latest news about BRISTOL-MYERS SQUIBB COMPANY

Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting	10:14am	BU
Bristol Myers: presents advances in lung cancer	08:58am	CF
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer	08:09am	BU
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes	06-02	RE

More news

Quotes 5-day view

Date	Price	Change
24-06-03	0.003	+50.00%
24-05-31	0.002	0.00%
24-05-30	0.002	0.00%
24-05-29	0.002	0.00%
24-05-28	0.002	0.00%

Real-time Boerse Frankfurt Warrants

Last update June 03, 2024 at 12:33 pm

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	BRISTOL-MYERS SQUIBB COMPANY
Issuer	Société Générale
WKN	SB01Q8
ISIN	DE000SB01Q81
Date issued	2020-06-09
Strike	61.26 $
Maturity	Unlimited
Parity	1 : 1
Emission price	8.85 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	9.84 €
Lowest since issue	0.002 €

Company Profile

Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 70.1% of net sales.

Sector

More about the company

Ratings for Bristol-Myers Squibb Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: Bristol-Myers Squibb Company

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

41.09 USD

Average target price

53.19 USD

Spread / Average Target

+29.46%

Consensus